SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $864,115 | +61.2% | 664,704 | +507.8% | 0.00% | – |
| Q3 2022 | $536,000 | +46.4% | 109,356 | +23.9% | 0.00% | – |
| Q2 2022 | $366,000 | -56.1% | 88,241 | -38.5% | 0.00% | – |
| Q1 2022 | $833,000 | -53.2% | 143,573 | -39.5% | 0.00% | – |
| Q4 2021 | $1,779,000 | +68.6% | 237,133 | +102.5% | 0.00% | – |
| Q3 2021 | $1,055,000 | -48.9% | 117,096 | -32.1% | 0.00% | – |
| Q2 2021 | $2,065,000 | -29.3% | 172,521 | -25.9% | 0.00% | -100.0% |
| Q1 2021 | $2,919,000 | -73.1% | 232,938 | -66.5% | 0.00% | -80.0% |
| Q4 2020 | $10,856,000 | +171.9% | 695,634 | +64.6% | 0.01% | +150.0% |
| Q3 2020 | $3,993,000 | +29.4% | 422,660 | +22.7% | 0.00% | 0.0% |
| Q2 2020 | $3,086,000 | +939.1% | 344,486 | +640.1% | 0.00% | – |
| Q1 2020 | $297,000 | +194.1% | 46,546 | +287.2% | 0.00% | – |
| Q4 2019 | $101,000 | -69.4% | 12,021 | -67.0% | 0.00% | -100.0% |
| Q3 2019 | $330,000 | -23.8% | 36,441 | -19.8% | 0.00% | 0.0% |
| Q1 2019 | $433,000 | -2.7% | 45,450 | +17.1% | 0.00% | 0.0% |
| Q4 2018 | $445,000 | -55.3% | 38,827 | -33.8% | 0.00% | -50.0% |
| Q3 2018 | $995,000 | +159.8% | 58,691 | +117.4% | 0.00% | +100.0% |
| Q2 2018 | $383,000 | -75.2% | 27,000 | -66.8% | 0.00% | -75.0% |
| Q1 2018 | $1,545,000 | +160.5% | 81,322 | +124.9% | 0.00% | +100.0% |
| Q4 2017 | $593,000 | -5.0% | 36,155 | -13.1% | 0.00% | 0.0% |
| Q3 2017 | $624,000 | +280.5% | 41,591 | +53.1% | 0.00% | +100.0% |
| Q1 2016 | $164,000 | +0.6% | 27,160 | +52.6% | 0.00% | 0.0% |
| Q4 2015 | $163,000 | -58.5% | 17,800 | -49.7% | 0.00% | -66.7% |
| Q2 2015 | $393,000 | -40.1% | 35,393 | -17.9% | 0.00% | -40.0% |
| Q4 2014 | $656,000 | +507.4% | 43,107 | +331.1% | 0.01% | +400.0% |
| Q3 2014 | $108,000 | -47.3% | 10,000 | -25.6% | 0.00% | -66.7% |
| Q2 2014 | $205,000 | – | 13,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |